Glioblastoma Multiforme (GBM) Market Treatment, Pipeline Review 2016 Glioblastoma Multiforme (GBM) Market | Página 2

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Glioblastoma Multiforme (GBM) therapeutics and enlists all their major and minor projects - The report assesses Glioblastoma Multiforme (GBM) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Glioblastoma Multiforme (GBM) Reasons To Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Glioblastoma Multiforme (GBM) - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Glioblastoma Multiforme (GBM) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Buy a Sample Copy of This Report @ http://www.radiantinsights.com/research/glioblastoma-multiforme-gbmpipeline-review-h1-2016/request-sample Table of Contents Table of Contents 2 Introduction 10 Glioblastoma Multiforme (GBM) Overview 11 Therapeutics Development 12 Glioblastoma Multiforme (GBM) - Therapeutics under Development by Companies 14 Glioblastoma Multiforme (GBM) - Therapeutics under Investigation by Universities/Institutes 30 Glioblastoma Multiforme (GBM) - Pipeline Products Glance 33 Glioblastoma Multiforme (GBM) - Products under Development by Companies 37 Glioblastoma Multiforme (GBM) - Products under Investigation by Universities/Institutes 57 Glioblastoma Multiforme (GBM) - Companies Involved in Therapeutics Development 61 Glioblastoma Multiforme (GBM) - Therapeutics Assessment 235 Drug Profiles 2